Latest News

NOX CEO interview on Radiotherapy Clinical Programs
St Vincent's Hospital study passes first milestone
DARRT-1 Clinical Study commences
NOX raises $10.8 M to advance clinical program
Evidence of Abscopal Responses in Patients
Corporate Presentation - Post Interim Clinical Data Release
FNN Interview with Noxopharm CEO
NOX Reports NOX66 Clinical Data
NOX closes $4m capital raising for US subsidiary Nyrada Inc
NOX receives FY17 R&D Tax Rebate